Abstract
Patients with Alzheimer's disease (AD) present high risk of developing type II diabetes mellitus (TD2), and this has an impact on various sectors of our society. The heterogeneous aggregation between the proteins related to these diseases, ²A and hIAPP, has been proposed as a potential molecular mechanism. However, the structural characteristics of the aggregates generated from these inte…